Spend just a few minutes watching prime time television with its endless pageant of commercials for antidepressants and anti-anxiety meds and you start to wonder if USA really means the United States of Affliction. Such “direct to consumer” drug advertising ties into one of the most far-reaching criticisms in revising the Diagnostic and Statistical Manual of Mental Disorders…
I came across the graphic below in Good Magazine online. Each pill represents one million psychiatric drug prescriptions. Of the 10 drugs shown, three are benzodiazepines prescribed for anxiety (Xanax, Ativan and Valium), and by far the most prescribed drug of the group is Xanax with 44 million prescriptions in 2009.
The murder-suicide of a Jackson County couple is at the center of a wrongful death, and product liability suit against New York pharmaceutical company. Forest Laboratories and Forest Pharmaceuticals are named as co-defendants in a lawsuit filed in Jackson Circuit Court on April 30 by Robin J. Hall.
It has been a routine week in my clinical and forensic practice. I evaluated a malpractice case involving a woman on the West Coast whose family doctor from a decade earlier kept prescribing Prozac to her for ten years without ever seeing her again. When she ran into emotional difficulty, she called this doctor who simply raised the dose and added a new drug, still without seeing her for a decade.
The Medicines and Healthcare Products Regulatory Agency (MHRA), the government agency in the UK responsible for medicines and medical devices, has issued a warning about potential SSRI birth defects related to the use of fluoxetine (Prozac). The MHRA issued the warning in its monthly drug safety update. The agency warns that there is a small risk of congenital cardiac defects in infants of mothers who took fluoxetine during the first trimester of pregnancy.